Future Direction in Pharmacotherapy for Non-neurogenic Male Lower Urinary Tract Symptoms
- 9 May 2013
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 64 (4) , 610-621
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- 365 TRPV1 and TRPV4 antagonists have synergistic effect for treating bladder overactivity in ratsEuropean Urology Supplements, 2012
- Prostate development and growth in benign prostatic hyperplasiaDifferentiation, 2011
- Urological aspects of the metabolic syndromeNature Reviews Urology, 2011
- Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaEuropean Urology, 2011
- Antimuscarinic Mechanisms and the Overactive Detrusor: An UpdateEuropean Urology, 2011
- Local Activation of Cannabinoid CB1Receptors in the Urinary Bladder Reduces the Inflammation-Induced Sensitization of Bladder AfferentsMolecular Pain, 2011
- Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitisProceedings of the National Academy of Sciences, 2010
- Association of C-reactive Protein and Lower Urinary Tract Symptoms in Men and Women: Results From Boston Area Community Health SurveyUrology, 2009
- Drug Insight: biological effects of botulinum toxin A in the lower urinary tractNature Reviews Endocrinology, 2008
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002